Front Neurol. 2025 Sep 8;16:1692475. doi: 10.3389/fneur.2025.1692475. eCollection 2025. PMID: 40990033.
Publicaciones: septiembre 2025
Changes in Infarct Volume and Cerebral Edema After Mechanical Thrombectomy in Patients With Stroke Randomized to ApTOLL or Placebo: A Secondary Analysis of APRIL Trial
Hernández-Pérez M, Valls-Carbó A, Hernández-Jiménez M et al. Stroke. 2025 Sep;56(9):2422-2430. doi: 10.1161/STROKEAHA.124.048917. Epub 2025 Jul 18. PMID: 40677233
Rare Variant Association Analysis Uncovers Involvement of VNN2 in Stroke Outcome
Alcaide-Consuegra E, Mola-Caminal M, Escaramís G et al. Stroke. 2025 Sep;56(9):2571-2578. doi: 10.1161/STROKEAHA.124.049365. Epub 2025 Jun 11. PMID: 40495801
Electronegative LDL strongly induces LRP1 release from human monocytes and macrophages
Puig N, Garcia E, Moncunill M et al. Clin Investig Arterioscler. 2025 Sep 9:500845. doi: 10.1016/j.arteri.2025.500845. Online ahead of print. PMID: 40930868
Minimally invasive evacuation for spontaneous supratentorial haemorrhage: scoping for candidates and hypothetical logistic burdens in a pragmatic scenario
Mosteiro A, Coronel-Coronel M, Pedrosa L et al. Neurosurg Rev. 2025 Sep 27;48(1):669. doi: 10.1007/s10143-025-03823-4.
https://pubmed.ncbi.nlm.nih.gov/41014383/
Abstract: Minimally invasive surgery (MIS) is being evaluated as a promising treatment for spontaneous intracerebral haemorrhage (ICH). Transitioning to early clot removal requires accurate estimation of eligible candidates in practical scenarios. We conducted a prospective population-based observational study of ICH across all public stroke centres in Catalonia-Spain, between 2020 and 2022. Patient characteristics, need for conventional surgery and clinical outcomes were recorded. Inclusion and exclusion criteria from major trials assessing MIS for ICH were retrospectively applied to obtain the number of potential candidates. Sensitivity analyses examined the impact of withdrawal of care (WoC) decisions and variations in
selection criteria on eligibility estimates. Among 2,197 reported ICH cases, 1,571 met the selection criteria and had complete follow-up to be analysed. Annually, 113 (14.4%) patients met the criteria for catheter plus thrombolysis evacuation
(MISTIE-III criteria), and 45 (5.7%) for parafascicular evacuation (ENRICH criteria). Eligibility rates varied considerably depending on age and haematoma volume thresholds, and with changes in WoC, which affected 20–29% of potential candidates.
Conventional evacuation was performed as a life-saving measure in 40 (5%) patients annually according to local protocols. If implemented, MIS protocols could increase the number of clot evacuation procedures in a range of 1.1–1.8 times. In a hypothetical scenario of MIS implementation for early ICH evacuation protocol in Catalonia, 5.7–14.4% of patients could potentially qualify for surgery. Consequently, the annual number of emergent clot evacuation procedures might increase 1.1-fold to 1.8-fold, highlighting substantial impact on healthcare infrastructure and resource planning.
Funding: The HIC-CAT registry was supported by the Instituto de Salud Carlos III (ISCIII) through the RICORS-ICTUS network (RD24/0009/0010). The study was also founded by the European Union program FEDER, and the European Regional Development Fund (ERDF) (PI22/0105).
European Stroke Organisation (ESO) standard operating procedure for white papers (expert consensus based clinical guidance)
Aguiar de Sousa D, Zietz A, Zedde M et al. Eur Stroke J. 2025 Sep;10(3):637-645. doi: 10.1177/23969873251316430. Epub 2025 Feb 4. PMID: 39904756
Rescue stenting after failed mechanical thrombectomy: The RES-CAT study
Collet-Vidiella R, Camps-Renom P, Núñez-Guillén A et al. Eur Stroke J. 2025 Sep;10(3):705-712. doi: 10.1177/23969873241308680. Epub 2025 Jan 2. PMID: 39745051
Trends in revascularization therapies for patients with acute stroke with large infarcts: a population-based study
Doncel-Moriano Cubero A, Rodríguez-Vázquez A, Rosa I et al. J Neurointerv Surg. 2025 Sep 12;17(10):1059-1065. doi: 10.1136/jnis-2025-023252. PMID: 40316318

